Successful reversal of transgene silencing in Chlamydomonas reinhardtii
Biotechnology Journal · 2024-01 · 19 (1)
DOI: 10.1002/biot.202300232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 23.11.2023. Verfasst von Rémy Beauchemin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Chlamydomonas reinhardtii. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Mitacs, Canada Research Chairs.
Abstract (Originalsprache)
Chlamydomonas reinhardtii has been successfully engineered to produce compounds of interest following transgene integration and heterologous protein expression. The advantages of this model include the availability of validated tools for bioengineering, its photosynthetic ability, and its potential use as biofuel. Despite this, breakthroughs have been hindered by its ability to silence transgene expression through epigenetic changes. Histone deacetylases (HDAC) are main players in gene expression. We hypothesized that transgene silencing can be reverted with chemical treatments using HDAC inhibitors. To analyze this, we transformed C. reinhardtii , integrating into its genome the mVenus reporter gene under the HSP70‐rbcs2 promoter. From 384 transformed clones, 88 (22.9%) displayed mVenus positive (mVenus + ) cells upon flow‐cytometry analysis. Five clones with different fluorescence intensities were selected. The number of integrated copies was measured by qPCR. Transgene expression levels were followed over the growth cycle and upon SAHA treatment, using a microplate reader, flow cytometry, RT‐qPCR, and western blot analysis. First, we observed that expression varies with the cell cycle, reaching a maximum level just before the stationary phase in all clones. Second, we uncovered that supplementation with HDAC inhibitors of the hydroxamate family, such as vorinostat (suberoylanilide‐hydroxamic‐acid, SAHA) at the initiation of culture increases the frequency (% of mVenus + cells) and the level of transgene expression per cell over the whole growth cycle, through histone deacetylase inhibition. Thus, we propose a new tool to successfully trigger the expression of heterologous proteins in the green algae C. reinhardtii , overcoming its main obstacle as an expression platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Biochemistry and Physics, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada.
- Plant Biology Research Group, Trois-Rivières, Québec, Canada.
ORCID-Profile: Natacha Merindol, Serge Basile Nouemssi, Isabel Desgagné-Penix
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Mitacs
- Canada Research Chairs
Zitieren
APA
Beauchemin, R., Merindol, N., Fantino, E., Lavoie, P., Nouemssi, S. B., Meddeb-Mouelhi, F., & Desgagné-Penix, I. (2024). Successful reversal of transgene silencing in Chlamydomonas reinhardtii. Biotechnology Journal, 19(1). https://doi.org/10.1002/biot.202300232
Vancouver
Beauchemin R, Merindol N, Fantino E, Lavoie P, Nouemssi SB, Meddeb-Mouelhi F, et al. Successful reversal of transgene silencing in Chlamydomonas reinhardtii. Biotechnology Journal. 2024;19(1). doi:10.1002/biot.202300232
BibTeX
@article{Beauchemin2024,
author = {Beauchemin, Rémy and Merindol, Natacha and Fantino, Elisa and Lavoie, Pamela and Nouemssi, Serge Basile and Meddeb-Mouelhi, Fatma and Desgagné-Penix, Isabel},
title = {Successful reversal of transgene silencing in Chlamydomonas reinhardtii},
journal = {Biotechnology Journal},
year = {2024},
volume = {19},
number = {1},
doi = {10.1002/biot.202300232}
}
EUVIMED